Venture Medical buys Medipyxis to expand wound care software

Venture Medical has acquired Medipyxis, a wound care EMR and practice operating system, and will keep it running as a separate platform. The deal comes as wound care providers face tighter Medicare reimbursement, heavier documentation demands and more claims scrutiny.

Why it matters: - Wound care practices are under pressure to do more with less as Medicare reimbursement changes narrow margins for inefficiency. - Medipyxis is built to reduce manual work across intake, documentation, scheduling, billing and inventory, which could help clinics handle more patients without adding staff. - Venture Medical is pairing software with its wound care products and reimbursement services to deepen its role in the sector.

What happened: - Venture Medical announced on September 29, 2026, that it acquired Medipyxis, Inc. - Medipyxis will operate as a wholly owned subsidiary of Venture Medical. - Damon Ebanks will continue leading Medipyxis as President. - Financial terms were not disclosed. - Venture Medical is based in Missoula, Montana.

The details: - Medipyxis was built specifically for wound care practices. - The platform combines AI-assisted referral intake, structured wound documentation, real-time eligibility verification, scheduling and route planning, credentialing alerts, product inventory tracking and billing in one system. - The software is designed to support the full workflow from patient intake to billable claim. - The company says the platform is aligned with Medicare coverage requirements and replaces disconnected manual tools many practices still use. - Venture Medical said it will provide Medipyxis the resources to reach more practices and patients. - Medipyxis was founded in 2024. - Venture Medical has operated since 2009 and serves mobile, facility-based and office-based wound care providers. - Venture Medical offers advanced wound care products, including skin substitutes, wound bed preparation and treatment systems, and wound care supplies.

Between the lines: - The acquisition fits a broader push to bundle clinical products, reimbursement support and software into one offering for wound care providers. - The timing reflects mounting pressure on practices as claims scrutiny rises, including the WISeR prior authorization model now operating in six states. - Venture Medical is positioning Medipyxis as a growth tool for practices that need better throughput without expanding administrative staff.

What's next: - Medipyxis will remain an independent platform in the near term. - Customers are expected to keep working with the same team and the same platform while Venture Medical adds capital, clinical expertise and reach. - Venture Medical expects to expand Medipyxis to more practices and patients.

The bottom line: - Venture Medical is betting that wound care providers want an integrated software stack that helps them navigate reimbursement pressure while spending less time on paperwork and more time with patients.

More information: Venture Medical | Medipyxis | Company on LinkedIn